Skip to Main Content

Author Details

Sandra Orsulic
David Geffen School of Medicine, University of California at Los Angeles
1992
113
43
PMIDPaper TitleJournal TitlePublished Year
36572991CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study.Cancer2023
37059310Metabolic dependencies and targets in ovarian cancer.Pharmacol Ther2023
36948887p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study.J Pathol Clin Res2023
36222710Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes.Clin Cancer Res2022
35387127Focal Serous Tubal Intra-Epithelial Carcinoma Lesions Are Associated With Global Changes in the Fallopian Tube Epithelia and Stroma.Front Oncol2022
36552773Ciliated Cells in Ovarian Cancer Decrease with Increasing Tumor Grade and Disease Progression.Cells2022
36479087Editorial: Molecular pathology and computational image analyses in gynecologic malignancies.Front Oncol2022
36497028Dynamic Changes in the Extracellular Matrix in Primary, Metastatic, and Recurrent Ovarian Cancers.Cells2022
35965569Computational pathology in ovarian cancer.Front Oncol2022
36230774FOXC2 Promotes Vasculogenic Mimicry in Ovarian Cancer.Cancers (Basel)2022
36197994Ovarian cancer cell fate regulation by the dynamics between saturated and unsaturated fatty acids.Proc Natl Acad Sci U S A2022
34645669Immunological configuration of ovarian carcinoma: features and impact on disease outcome.J Immunother Cancer2021
33613630Identification of Infertility-Associated Topologically Important Genes Using Weighted Co-expression Network Analysis.Front Genet2021
34921160Integrated single-cell transcriptome analysis reveals heterogeneity of esophageal squamous cell carcinoma microenvironment.Nat Commun2021
34965417Human iPSC-derived fallopian tube organoids with BRCA1 mutation recapitulate early-stage carcinogenesis.Cell Rep2021
32400970Tumors defective in homologous recombination rely on oxidative metabolism: relevance to treatments with PARP inhibitors.EMBO Mol Med2020
33043018Editorial: The Tumor Microenvironment: Recent Advances and Novel Therapeutic Approaches.Front Cell Dev Biol2020
32766252Are Epithelial Ovarian Cancers of the Mesenchymal Subtype Actually Intraperitoneal Metastases to the Ovary?Front Cell Dev Biol2020
32698955Dual targeting of GSK3B and HDACs reduces tumor growth and improves survival in an ovarian cancer mouse model.Gynecol Oncol2020
32312965Inhibition of collagen XI alpha 1-induced fatty acid oxidation triggers apoptotic cell death in cisplatin-resistant ovarian cancer.Cell Death Dis2020
32555365Clinical and pathological associations of PTEN expression in ovarian cancer: a multicentre study from the Ovarian Tumour Tissue Analysis Consortium.Br J Cancer2020
32554541Development and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE).Clin Cancer Res2020
32473302Prognostic gene expression signature for high-grade serous ovarian cancer.Ann Oncol2020
32376288HOXB13 controls cell state through super-enhancers.Exp Cell Res2020
30704616Can molecular subtyping be used to triage women with advanced ovarian cancer to Primary Debulking Surgery or Neoadjuvant Chemotherapy?Gynecol Oncol2019
29622464A Comprehensive Pan-Cancer Molecular Study of Gynecologic and Breast Cancers.Cancer Cell2018
30134598rs495139 in the TYMS-ENOSF1 Region and Risk of Ovarian Carcinoma of Mucinous Histology.Int J Mol Sci2018
30211161A Paradoxical Correlation of Cancer-Associated Fibroblasts With Survival Outcomes in B-Cell Lymphomas and Carcinomas.Front Cell Dev Biol2018
30120290Inflammation is a key contributor to ovarian cancer cell seeding.Sci Rep2018
29979793Variants in genes encoding small GTPases and association with epithelial ovarian cancer susceptibility.PLoS One2018
29555990Adult height is associated with increased risk of ovarian cancer: a Mendelian randomisation study.Br J Cancer2018
29502561MyD88 and TLR4 Expression in Epithelial Ovarian Cancer.Mayo Clin Proc2018
29769618Inhibitor of apoptosis proteins (IAPs) mediate collagen type XI alpha 1-driven cisplatin resistance in ovarian cancer.Oncogene2018
27677730No Evidence That Genetic Variation in the Myeloid-Derived Suppressor Cell Pathway Influences Ovarian Cancer Survival.Cancer Epidemiol Biomarkers Prev2017
28412735Glucose deprivation elicits phenotypic plasticity via ZEB1-mediated expression of NNMT.Oncotarget2017
28189535Response to the Letter to the Editor on: "A COL11A1-correlated pan-cancer gene signature of activated fibroblasts for the prioritization of therapeutic targets," Cancer Lett. 2016 Nov 28;382(2):203-214.Cancer Lett2017
28346442Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.Nat Genet2017
29049607Dose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer.JAMA Oncol2017
29166612Impediment of Replication Forks by Long Non-coding RNA Provokes Chromosomal Rearrangements by Error-Prone Restart.Cell Rep2017
25940428No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.Gynecol Oncol2016
27634875FOXC2 augments tumor propagation and metastasis in osteosarcoma.Oncotarget2016
27609069A COL11A1-correlated pan-cancer gene signature of activated fibroblasts for the prioritization of therapeutic targets.Cancer Lett2016
26716409Sphingosine kinase 1 is required for TGF-β mediated fibroblastto- myofibroblast differentiation in ovarian cancer.Oncotarget2016
26840454Germline polymorphisms in an enhancer of PSIP1 are associated with progression-free survival in epithelial ovarian cancer.Oncotarget2016
25336561Candidate genetic modifiers for breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers.Cancer Epidemiol Biomarkers Prev2015
26348314Suboptimal cytoreduction in ovarian carcinoma is associated with molecular pathways characteristic of increased stromal activation.Gynecol Oncol2015
26424751Common variants at the CHEK2 gene locus and risk of epithelial ovarian cancer.Carcinogenesis2015
26399219Epithelial-Mesenchymal Transition (EMT) Gene Variants and Epithelial Ovarian Cancer (EOC) Risk.Genet Epidemiol2015
26391404Cis-eQTL analysis and functional validation of candidate susceptibility genes for high-grade serous ovarian cancer.Nat Commun2015
26807442Common Genetic Variation in Circadian Rhythm Genes and Risk of Epithelial Ovarian Cancer (EOC).J Genet Genome Res2015
  • 1 - 50 of 113

Recommended Authors

Aleksandra M Michalowski
Center for Cancer Research, National Cancer Institute
Career Start Year 2010
Number of shared co-authors 1
Cristina Ivan
The University of Texas MD Anderson Cancer Center
Career Start Year 2010
Number of shared co-authors 13
Kris Ylaya
Center for Cancer Research, National Cancer Institute
Career Start Year 2008
Number of shared co-authors 13
Yingmei Wang
Tianjin Medical University General Hospital
Career Start Year 2007
Number of shared co-authors 3
Christopher A Bristow
The University of Texas MD Anderson Cancer Center
Career Start Year 2005
Number of shared co-authors 16
Brigitte L Th??riault
Ontario Institute for Cancer Research, University Avenue
Career Start Year 2004
Number of shared co-authors 1
Limei Hu
Aier Eye Hospital of Wuhan University
Career Start Year 2001
Number of shared co-authors 5
Saravut J Weroha
Mayo Clinic
Career Start Year 2001
Number of shared co-authors 21
Aparna A Kamat
Houston Methodist Hospital
Career Start Year 2000
Number of shared co-authors 3
Steve E Kalloger
University of British Columbia
Career Start Year 2000
Number of shared co-authors 31
Tobias Sj??blom
Uppsala University
Career Start Year 1999
Number of shared co-authors 1
Jun Yao
The University of Texas MD Anderson Cancer Center
Career Start Year 1997
Number of shared co-authors 9
Hai Hu
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Career Start Year 1996
Number of shared co-authors 16
Paulette Mhawech-Fauceglia
University of Southern California
Career Start Year 1995
Number of shared co-authors 17
Alexander D Borowsky
University of California Davis Health
Career Start Year 1995
Number of shared co-authors 10
Phillip Buckhaults
University of South Carolina
Career Start Year 1993
Number of shared co-authors 2
Jan Paul Medema
Oncode Institute
Career Start Year 1993
Number of shared co-authors 6
Bhaskar Kallakury
Georgetown University
Career Start Year 1993
Number of shared co-authors 1
Ernst Lengyel
University of Chicago
Career Start Year 1993
Number of shared co-authors 30
Barry R Davies
Oncology R&D
Career Start Year 1992
Number of shared co-authors 7
Kornelia Polyak
Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School
Career Start Year 1991
Number of shared co-authors 12
Rosemarie Schmandt
The University of Texas MD Anderson Cancer Center, UT MD Anderson Cancer Center
Career Start Year 1991
Number of shared co-authors 8
Patricia A Shaw
Princess Margaret Cancer Centre, University Avenue
Career Start Year 1990
Number of shared co-authors 46
Stephen M Hewitt
Center for Cancer Research, National Cancer Institute
Career Start Year 1988
Number of shared co-authors 30
Wei Zhang
The University of Texas MD Anderson Cancer Center
Career Start Year 1988
Number of shared co-authors 19
Enzo Medico
Candiolo Cancer Institute, Fondazione del Piemonte per l'Oncologia (FPO) - IRCCS
Career Start Year 1988
Number of shared co-authors 1
William C Hahn
Broad Institute of MIT and Harvard, USA Dana-Farber Cancer Institute
Career Start Year 1987
Number of shared co-authors 12
Rakesh Kumar
Rutgers New Jersey Medical School
Career Start Year 1987
Number of shared co-authors 9
John A Copland
Mayo Clinic Jacksonville
Career Start Year 1982
Number of shared co-authors 6
Francisca Vazquez
Broad Institute of MIT and Harvard
Career Start Year 1979
Number of shared co-authors 6

Collaborators

Beth Y Karlan
David Geffen School of Medicine, University of California los angeles
Co-authored papers 57
Jenny Lester
David Geffen School of Medicine, University of California at Los Angeles
Co-authored papers 36
Jacek Gronwald
International Hereditary Cancer Center, Pomeranian Medical University
Co-authored papers 27
Peter A Fasching
Otto-Friedrich-University Bamberg
Co-authored papers 26
Paul D P Pharoah
Center for Cancer Genetic Epidemiology, University of Cambridge
Co-authored papers 26
Jan Lubinski
Pomeranian Medical University
Co-authored papers 26
Susan J Ramus
School of Clinical Medicine, University of NSW Sydney, Lowy Cancer Research Centre
Co-authored papers 26
Ellen L Goode
Mayo Clinic College of Medicine
Co-authored papers 25
Marc T Goodman
Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Co-authored papers 24
Joellen M Schildkraut
Rollins School of Public Health, Emory University
Co-authored papers 23
Andrew Berchuck
Duke School of Medicine
Co-authored papers 23
Usha Menon
College of Nursing, University of South Florida
Co-authored papers 23
Jenny Chang-Claude
German Cancer Research Center (DKFZ)
Co-authored papers 22
Aleksandra Gentry-Maharaj
UCL EGA Institute for Women's Health, University College London
Co-authored papers 22
Linda E Kelemen
Hollings Cancer Center, Medical University of South Carolina
Co-authored papers 21
Georgia Chenevix-Trench
QIMR Berghofer Medical Research Institute
Co-authored papers 21
Ian G Campbell
Co-authored papers 21
Simon A Gayther
Cedars-Sinai Medical Center
Co-authored papers 21
Joseph H Rothstein
Co-authored papers 20
Lynne R Wilkens
University of Hawaii Cancer Center
Co-authored papers 20
Celeste Leigh Pearce
University of Michigan School of Public Health ann arbor
Co-authored papers 20
Anna H Wu
University of Southern California
Co-authored papers 20
Weiva Sieh
Co-authored papers 20
Alice S Whittemore
Co-authored papers 20
Cezary Cybulski
International Hereditary Cancer Center, Pomeranian Medical University
Co-authored papers 19
Tanja Pejovic
Oregon Health & Science University
Co-authored papers 19
Diether Lambrechts
Co-authored papers 19
Malcolm C Pike
Memorial Sloan-Kettering Cancer Center
Co-authored papers 19
Nicolas Wentzensen
National Cancer Institute, National Institutes of Health
Co-authored papers 19
Honglin Song
University of Cambridge
Co-authored papers 19
Release 1.2